The Lancet Public Health, August 2020, Volume 5, Issue 8, Pages e414-e459
Read the current issue of The Lancet Public Health, a monthly open access journal contributing to advancing public health practice and policy making worldwide
Read the current issue of The Lancet Public Health, a monthly open access journal contributing to advancing public health practice and policy making worldwide
In the past 15 years, treatment frameworks for newly diagnosed multiple myeloma have radically changed. It is important to recall that as recently as 2010,…
Our results suggest that age, chronic comorbidities, and not being fully vaccinated might be greater risk factors for severe COVID-19 outcomes in patients with IMIDs…
Population-wide screening of children for presymptomatic early-stage type 1 diabetes is gaining momentum. Studies have demonstrated feasibility and acceptance, and shown that the rate of…
Total national health expenditure is associated with geographical inequalities in lymphoid malignancy prognosis. Policy decisions on allocating economic resources and implementing evidence-based models of care…
The purpose of this European Society for Radiotherapy and Oncology (ESTRO) project, endorsed by the European Association of Urology, is to explore expert opinion on…
In patients with an acute coronary syndrome, intravascular ultrasound-guided implantation of contemporary drug-eluting stents resulted in a lower 1-year rate of the composite outcome of…
The Lancet’s interactive Picture Quiz Gallery hosts a new picture quiz each month. Play the picture quiz to test your medical knowledge and diagnostic skills.…
Cabozantinib shows promising activity in patients with MPPGs.
Cabozantinib in advanced adrenocortical carcinoma showed promising efficacy with a manageable and anticipated safety profile. Further prospective studies with cabozantinib alone and in combination with…
The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…